The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
Highest end of day price: $216.66 USD on 2025-03-10
Lowest end of day price: $33.71 USD on 2013-01-08
Year | Performance |
---|---|
2025 | 6.49% |
2024 | 11.19% |
2023 | -4.56% |
2022 | 19.34% |
2021 | 28.45% |
2020 | 19.65% |
2019 | -0.77% |
2018 | -6.32% |
2017 | 54.96% |
2016 | 8.70% |
2015 | -10.09% |
2014 | 25.89% |
2013 | 50.37% |
Company | Stock price | Change 1d% | Country |
---|---|---|---|
![]() Pfizer PFE | $24.54 | -1.21% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $49.75 | -1.85% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $819.36 | 0.90% | ๐บ๐ธ USA |
![]() Amgen AMGN | $295.22 | -0.70% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $109.98 | -1.15% | ๐บ๐ธ USA |
![]() Biogen BIIB | $130.65 | -1.25% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $40.86 | -3.84% | ๐ฌ๐ง UK |
![]() AstraZeneca AZN | $74.42 | -0.77% | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | $124.39 | -0.50% | ๐บ๐ธ USA |